Researchers from Tufts University have developed 3D human tissue culture models for the CNS. This may facilitate the discovery of new treatment methods for neurodegenerative diseases.
Researchers have revealed that taking a simple test within a week of a stroke may help to predict the long-term prognosis of a patient; this information could be beneficial for patients when making treatment and long-term care decisions.
In the largest exome sequencing of autism spectrum disorder to date, researchers have identified 102 possible gene candidates.
Digital brain simulates patterns of atrophy associated with neurodegenerative diseases through altering the initial starting zone of toxic proteins.
A pioneering treatment, an antibody termed PRN100, is to be given to a patient with sporadic Creutzfeldt-Jakob disease for the first time.
Novartis (Basel, Switzerland) have announced US FDA and EMA filing acceptance for siponimod, a new drug developed to treat secondary progressive multiple sclerosis in adults.
Chinese tech firm Tencent and British healthcare technology company Medopad are joining forces to develop an artificial intelligence model with the ability to assess motor function in patients with Parkinson’s disease.
A recent study indicates that a chronic periodontal pathogen infection could result in the development of Alzheimer’s disease.
Antiretroviral therapy with efavirenz in HIV-positive pregnant women has been reported to increase the risk of neurological conditions in offspring.
Researchers have revealed that reducing mutant huntingtin protein in the brain could restore cognitive and psychiatric impairments in mice.